CAMBRIDGE, MA, Leader in nanopharmaceuticals, announced that it has closed a $15M Series D financing with participation from new investor, CVF, as well as from all other existing investors Polaris, Venrock, Lilly Ventures, Lux Capital, and Bessemer Venture Partners.
Read More